PROSTATA BEZI ADENOMASI BILAN OG‘RIGAN BEMORLARDA ZAMONAVIY DAVOLASH STRATEGIYALARI
Article Sidebar
Main Article Content
Аннотация:
Mazkur ilmiy tezisda prostata bezi adenomasi (benign prostata giperplaziyasi — BPG) bilan og‘rigan bemorlarni zamonaviy davolash yondashuvlari tahlil qilindi. Kasallikning patogenezi, klinik kechishi hamda farmakologik va jarrohlik usullarining samaradorligi ilmiy manbalar asosida yoritildi. Xususan, α1-adrenoblokatorlar, 5-α-reduktaza ingibitorlari, kombinatsion terapiya va minimal invaziv jarrohlik usullarining qo‘llanish natijalari ko‘rib chiqildi. Tadqiqotlar shuni ko‘rsatadiki, individual yondashuv va bosqichma-bosqich davolash taktikasi bemorlarning hayot sifatini sezilarli yaxshilaydi va asoratlar xavfini kamaytiradi.
Article Details
Как цитировать:
Библиографические ссылки:
Gravas S., et al. EAU Guidelines on Management of Non-neurogenic Male LUTS. — 2023. — p. 15–18.
Roehrborn C.G. Benign Prostatic Hyperplasia: Etiology and Pathophysiology. — 2019. — p. 45–52.
Emberton M., et al. Progression of BPH: systematic review. Eur Urol. — 2018. — p. 120–124.
Djavan B., et al. Alpha-blockers in BPH treatment. Urology. — 2017. — p. 230–236.
McConnell J.D., et al. The effect of finasteride on BPH progression. NEJM. — 2003. — p. 2387–2395.
Roehrborn C.G., et al. MTOPS Study. — 2010. — p. 650–662.
Cornu J.N., et al. HoLEP vs TURP meta-analysis. Eur Urol. — 2015. — p. 798–808.
Malling B., et al. Prostatic artery embolization review. — 2019. — p. 210–218.
Roehrborn C.G. UroLift System outcomes. Can J Urol. — 2017. — p. 8802–8813.
American Urological Association Guideline: BPH. — 2021. — p. 32–40.
Speakman M.J., et al. Medical therapy of BPH. — 2015. — p. 101–109.
Kaplan S.A. Combination therapy in LUTS/BPH. — 2016. — p. 55–63.